- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 111
Daily Deal Round Up: October 4, 2021
Sesame Ventures helped lazy eye treatment developer Luminopia raise $12m while UPS, Qualcomm and Mercado Libre exited courier marketplace Mandaê in a purchase by Nuvemshop.
Oct 4, 2021Daily deal net: October 4, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oct 4, 2021Exscientia establishes Nasdaq listing
SoftBank invested $125m through a $160m private placement as portfolio company and cancer drug developer Exscientia went public in an offering sized at nearly $305m.
Oct 4, 2021AFB attracts corporates for $102m Fund II
Boehringer Ingelheim Venture Fund and Pierre Fabre have made capital commitments to Advent France Biotechnology’s second fund.
Oct 4, 2021Exscientia establishes Nasdaq listing
The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.
Oct 4, 2021Daily Deal Round Up: October 1, 2021
Corporate-backed asset management software developer Zero Hash raised $35m in series C funding while warehouse robotics provider VisionNav closed its own series C round.
Oct 1, 2021Daily deal net: October 1, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oct 1, 2021Oxford Nanopore fetches $478m in IPO
Tencent, Nikon, Amgen and Illumina all scored exits as the DNA sequencing provider's shares popped in the wake of its flotation.
Oct 1, 2021ContractPodAi drafts SoftBank to raise $115m
The legal digitisation software provider's series C round was led by SoftBank Vision Fund 2 and quintupled its valuation.
Oct 1, 2021Micreos makes space for new funding
Altria-backed Micreos is working on a clinical platform that will facilitate the targeted killing of unwanted bacteria, and has just secured $37.5m.
Oct 1, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


